David M. Spencer insider trades: Bellicum Pharmaceuticals (BLCM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 4, 2018 | BLCM | ↓ Sell | 10,000 | $7.04 | $70K | Direct | Sep 5, 2018 (1d) |
| Jul 18, 2018 | BLCM | ↓ Sell | 40,000 | $7.63 | $305K | Direct | Jul 20, 2018 (2d) |
| Jul 10, 2017 | BLCM | ↓ Sell | 10,000 | $11.54 | $115K | Direct | Jul 12, 2017 (2d) |
| Dec 5, 2016 | BLCM | ↓ Sell | 5,000 | $20.00 | $100K | Direct | Dec 5, 2016 (0d) |
| Dec 1, 2016 | BLCM | ↓ Sell | 5,000 | $17.52 | $88K | Direct | Dec 5, 2016 (4d) |
| Sep 23, 2016 | BLCM | ↓ Sell | 16,500 | $19.88 | $328K | Direct | Sep 23, 2016 (0d) |
| Sep 20, 2016 | BLCM | ↓ Sell | 2,500 | $20.01 | $50K | Direct | Sep 20, 2016 (0d) |
| Aug 15, 2016 | BLCM | ↓ Sell | 1,000 | $20.00 | $20K | Direct | Aug 17, 2016 (2d) |
| Jul 27, 2016 | BLCM | ↓ Sell | 10,000 | $15.00 | $150K | Direct | Jul 29, 2016 (2d) |
| Dec 1, 2015 | BLCM | ↓ Sell | 5,000 | $22.95 | $115K | Direct | Dec 3, 2015 (2d) |
| Sep 11, 2015 | BLCM | ↓ Sell | 5,000 | $19.00 | $95K | Direct | Sep 15, 2015 (4d) |
| Jun 16, 2015 | BLCM | ↓ Sell | 20,000 | $22.96 | $459K | Direct | Jun 18, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David M. Spencer's insider trades
David M. Spencer is Chief Technology Officer at Bellicum Pharmaceuticals (BLCM). Since Jun 16, 2015, David has reported no open-market purchases and 12 sales worth $1.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (5 filings), shares withheld for taxes (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLCM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.